Novaferon (recombinant anti-tumor and anti-virus protein) / Genova 
Welcome,         Profile    Billing    Logout  
 11 Diseases   5 Trials   5 Trials   28 News 
2 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Novaferon (recombinant anti-tumor and anti-virus protein) / Genova
ChiCTR2000029573: A multicenter, randomized, open, controlled clinical study to evaluate the efficacy and safety of recombinant cytokine gene-derived protein injection in combination with standard therapy in patients with novel coronavirus infection

Recruiting
4
480
China
antiviral therapy and Chinese medicine treatment ;antiviral therapy, Chinese medicine treatment, and Novaferon atomization ;antiviral therapy and Chinese medicine treatment ;antiviral therapy, Chinese medicine treatment, and Novaferon atomization
The First Affiliated Hospital of Medical College of Zhejiang University; The First Affiliated Hospital of Medical College of Zhejiang University, coordinater
novel coronavirus pneumonia
 
 
NCT02349984: Recombinant Anti-tumor and Anti-virus Protein for Injection in Treatment of Metastatic Colorectal Cancer

Recruiting
2/3
105
RoW
Recombinant anti-tumor and anti-virus protein for injection, Novaferon, Saline Injection, Brand name: Novaferon
Beijing Genova Biotech Company, Ltd.
Metastatic Colorectal Cancer
05/15
05/15

Download Options